Castor EDC Consulting, Implementation & Integration

Castor is an API-first clinical data platform built around Castor EDC/CDMS, with native eCOA/ePRO, eConsent, eRecruitment and a fully decentralized clinical trial layer. Castor has supported more than 15,000 studies with 8 million patients across 90+ countries, including 450+ biopharma trials and work for many of the top 20 pharmaceutical companies. The platform is particularly strong in academic research, small-to-mid biotech, rare disease, investigator-initiated trials and decentralized/hybrid studies where speed of build and a single validated system across EDC, ePRO and eConsent matter more than highly customized sponsor frameworks. IntuitionLabs helps sponsors, biotechs and CROs implement Castor at scale, integrate it with their CTMS, eTMF, IRT and safety stack, validate it for 21 CFR Part 11 and ICH E6(R3) GCP, and layer validated AI workflows on top of the Castor REST API.

Castor occupies a different segment from the legacy enterprise EDCs. Medidata Rave and Oracle Clinical One dominate large global Phase III and post-marketing programs at top-20 pharma, while Veeva Vault CDMS is the fastest-growing modern challenger inside Veeva-standardized organizations. Castor is typically chosen when sponsors need a fast build, a native ePRO/eConsent/DCT bundle and an open REST API rather than a heavyweight stack — common in biotech, rare disease, medical device, investigator-initiated and academic trials. IntuitionLabs runs trials across all four platforms and helps sponsors choose the right system per program, sometimes operating a hybrid stack (e.g. Rave for pivotal trials and Castor for early-phase and IIT) under a single validation and reporting framework.

A Castor rollout typically follows four phases: discovery (study portfolio mapping, integration requirements with CTMS/eTMF/IRT, sponsor SOP alignment, decentralization strategy), build (eCRF/library design, edit checks, ePRO instrument configuration, eConsent form design with multimedia comprehension checks, role-based access and signature workflows), validation (UAT, IQ/OQ/PQ aligned to ISPE GAMP 5 Category 4) and rollout (site activation, user training, sponsor and CRO onboarding, hypercare and adaptive design support). For a single Phase II study with native ePRO and eConsent, a validated production build typically takes 6-10 weeks. Enterprise programs with multi-system integrations (Rave, Veeva CTMS, Suvoda IRT, Oracle Argus safety) generally take 12-20 weeks. IntuitionLabs accelerates the work with reusable Castor study libraries, validated form templates and integration accelerators that have already been deployed in regulated environments.

Yes — the Castor EDC REST API exposes endpoints for Study, Record, DataPoint, SurveyPackage, User, Field and audit objects, secured by industry-standard OAuth 2.0 and rate-limited at the documented X-RateLimit thresholds. We routinely build integrations between Castor and CTMS platforms (Veeva Vault CTMS, Medidata CTMS), sponsor eTMFs (Veeva Vault eTMF, Phlexglobal), IRT/RTSM (Suvoda, Calyx), safety databases (Oracle Argus, ArisGlobal LifeSphere), labs, imaging vendors, RWE/RWD warehouses and identity providers (Azure AD, Okta). We typically use iPaaS tooling like Workato, Boomi or MuleSoft, with validation packages aligned to MHRA GxP data integrity and FDA Data Integrity guidance.

Castor provides the technical controls needed to support 21 CFR Part 11, EU Annex 11 and ICH E6(R3) Good Clinical Practice: Part 11-compliant electronic signatures with printed name, date/time and meaning of signature; immutable per-field audit trails; granular role-based access; configurable session policy; and ISO 27001 and HIPAA-aligned hosting. Like any GxP system, full compliance is a shared responsibility — the sponsor remains accountable for validated configuration, periodic reviews, change control and supplier qualification of Castor itself. IntuitionLabs builds the validation pack, periodic review framework and supplier audit support that bridge out-of-the-box capability to inspection-ready operations. See our full Castor validation services.

Castor is one of the few platforms that combines EDC, ePRO, eCOA, eConsent and eRecruitment natively in a single validated codebase — eliminating the middleware tax that plagues bolt-together DCT stacks. Patients can consent remotely with multimedia comprehension checks, complete ePRO/eCOA on their own device (with offline capability for low-connectivity settings), and have data flow directly into the same study database that investigators and monitors use. This architecture directly supports the FDA's Decentralized Clinical Trials guidance and EMA recommendations on decentralized elements of clinical trials. IntuitionLabs designs DCT programs that combine Castor with telehealth, home-health vendors, wearables, direct-to-patient logistics and remote monitoring under a single validated SOP and audit trail.

Castor sits in the middle of a clinical operations stack and rarely operates alone. We build site activation flows that push milestones from Castor to Veeva Vault CTMS and pull recruitment status back; eTMF flows that reconcile site documents and signed essentials with Veeva Vault eTMF, Phlexglobal or Florence eHub; randomization and supply flows with Suvoda or Calyx IRT/RTSM; SAE auto-routing to Oracle Argus or ArisGlobal LifeSphere with E2B(R3) message construction; and lab data ingestion from central labs and specialty vendors with CDISC-conformant transformation. All integrations are version-controlled, validated and monitored.

Castor exports raw clinical data in formats that downstream statistical programming teams transform into CDISC SDTM and CDISC ADaM for regulatory submission. The Castor REST API also makes near-real-time data extracts straightforward, which is critical for adaptive designs and DSMB reviews. IntuitionLabs provides SDTM/ADaM mapping specifications, validation against Define-XML standards, and Pinnacle 21 conformance review aligned to FDA and PMDA Study Data Technical Conformance Guides. We also pipeline Castor extracts into Snowflake or Databricks for cross-study analytics, RBQM dashboards and real-world data linkage.

Castor itself has begun adding AI features (notably AI-assisted form build and protocol-driven build acceleration). IntuitionLabs builds and validates additional AI capabilities on top of the Castor REST API: AI-assisted edit-check authoring from the protocol; AI-driven medical coding to MedDRA and WHODrug; risk-based monitoring dashboards that flag anomalous sites, subjects and forms; automatic protocol deviation detection from EDC + ePRO patterns; AI-generated query text and prioritization; ICF amendment differencing for eConsent; and natural-language search across study data, surveys and audit trail. We connect frontier models (Anthropic Claude, OpenAI GPT, Google Gemini) through zero-retention enterprise endpoints with full audit logging back into Castor. Explore Castor AI integration.

Academic medical centers, investigator-initiated trial (IIT) groups and rare disease networks adopt Castor because the build is fast, the per-study cost structure scales down, and EDC/ePRO/eConsent are in one validated platform — reducing the operational lift on small research teams. Castor is widely used by academic centers in Europe and North America, and supported the data capture for many rare disease registries and natural history studies referenced in publications and on ClinicalTrials.gov. IntuitionLabs has experience aligning Castor with academic HRPP/IRB workflows, single IRB models, NIH-funded study reporting, and reporting obligations to registries such as the ClinicalTrials.gov PRS and the EU CTIS.

Medical device and IVD trials add a regulatory layer on top of GCP: 21 CFR Part 812 for IDE studies, ISO 14155:2020 for global GCP for medical devices, and the EU MDR/IVDR for European post-market clinical follow-up. Castor is widely used in IDE, 510(k) clinical, De Novo and PMA support studies — including studies that secured FDA De Novo clearance with 1,000+ participants. IntuitionLabs configures Castor study libraries with device-specific data structures (deficiency reporting, UDI capture, device performance endpoints), connects them to PMS/PMCF reporting and complaint handling, and validates the resulting environment to ISO 14155 and 21 CFR Part 11 jointly.

Castor exposes the structured data and audit trail that an RBQM program needs to operate at scale: per-field audit history, query history, ePRO completion patterns, eConsent timing, screen-failure rates and protocol deviation tracking — all accessible via the REST API. We layer that into central monitoring dashboards aligned to the TransCelerate RBQM framework, the FDA's risk-based approach to monitoring guidance, and the risk-based quality management principles in ICH E6(R3). AI-assisted anomaly detection on top of Castor reduces the number of low-value on-site visits and lets monitors focus on truly high-risk sites and subjects.

Castor is sold on a subscription model that varies by study size, module mix (EDC, ePRO, eConsent, DCT add-ons), expected subject count and contract term. Public list pricing is not disclosed by the vendor; published comparisons (e.g. Capterra and analyst write-ups) generally position Castor as more cost-efficient than legacy enterprise EDCs for biotech and academic portfolios, particularly when ePRO and eConsent are needed. True TCO is driven by study build cost, integration scope, validation depth, sandbox/UAT environments and ongoing managed services. IntuitionLabs helps clients model a right-sized Castor deployment, including a hybrid sourcing model where Castor handles early-phase and DCT-heavy work while a legacy EDC handles pivotal Phase III studies — often cheaper in aggregate than standardizing on a single vendor.

Once Castor is live, work shifts from project to operations: onboarding new studies and sites, study build for protocol amendments, ePRO instrument updates, user provisioning and decommissioning, validation of new Castor platform releases, integration health monitoring, periodic reviews, and audit support during FDA BIMO, EMA, MHRA and sponsor inspections. IntuitionLabs offers tiered managed services — study-build-as-a-service, validation-on-demand for new modules and integrations, RBQM dashboard operations, risk-based regression testing for each Castor release, and inspection support including responses to Form FDA 483 observations. See our full managed services offering.